Free Trial

ECO Animal Health Group Interim Earnings Report

ECO Animal Health Group logo
GBX 54.50 +1.00 (+1.87%)
As of 12:17 PM Eastern

ECO Animal Health Group EPS Results

Actual EPS
-GBX 2.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ECO Animal Health Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ECO Animal Health Group Announcement Details

Quarter
Interim
Time
Before Market Opens

Conference Call Resources

Remove Ads

ECO Animal Health Group Earnings Headlines

Elon Tax Shock?
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
See More ECO Animal Health Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ECO Animal Health Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ECO Animal Health Group and other key companies, straight to your email.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

View ECO Animal Health Group Profile

More Earnings Resources from MarketBeat